參考資料 | Coppertone

水寶寶嬰幼兒系列

IQVIA: ProVoice USA Survey fielded from Aug 2018 – Jul 2019
Qualitative/Quantitative Composition and Function of Ingredients:1612450 Coppertone Water Babies/Kids Tear Free Lotion SPF50, 24 Feb 2020
Clinical report HT200617- EVALUATION OF THE STINGING POTENTIAL OF PRODUCTS IN HUMAN EYES
Clinical report HT201210, Summary of Safety and Efficacy Data (SSED) – UI 1612450 Formular S71-143, Feb 24, 2020
Clinical report - SR13-22 FINAL REPORT – SUN PROTECTION FACTOR (SPF)

IQVIA: ProVoice USA Survey fielded from Aug 2018 – Jul 2019
Summary of Safety and Efficacy Data (SSED) – UI 1614048, Moisturization 19536
Safety and tolerability clinical reports 19556, 19512, 19287, 19285, 19286
Summary of Safety and Efficacy Data (SSED) – UI 1614048, SPF Report for Study 19201 (SR16-18);CW Report NT2017-002 (FDA);CW Report NT2017-001 (ISO);UVA Report 19316 (ISO);SPF Static 19546 (FDA)
Summary of Safety and Efficacy Data (SSED) – UI 1614048, SPF Report for Study 19201 (SR16-18)

IQVIA: ProVoice USA Survey fielded from Aug 2018 – Jul 2019
Summary of Safety and Efficacy Data (SSED) – UI 1614048, Moisturization 19536
Qualitative/quantitative composition of ingredients 1613838.
Summary of Safety and Efficacy Data (SSED) – UI 1613838,SPF Report for Study 19201 (SR16-18) 19556 In Home Use Babies 6 months to 3 years of age
Summary of Safety and Efficacy Data (SSED) – UI 1613838. SPF Report for Study 19201 (SR16-18);CW Report NT2017-002 (FDA);CW Report NT2017-001 (ISO);UVA Report 19316 (ISO);SPF Static 19546 (FDA)
Summary of Safety and Efficacy Data (SSED) – UI 1614048, Moisturization 19536. Qualitative/quantitative composition of ingredients

IQVIA: ProVoice USA Survey fielded from Aug 2018 – Jul 2019
Summary of Safety and Efficacy Data (SSED) – UI 1614117, Acnegenicity/ Comedogenicity clinical study 20170. Top 2 boxes: The product absorbed quickly 95.2%
Summary of Safety and Efficacy Data (SSED) – UI 1614117, Acnegenicity/ Comedogenicity clinical study 20170
Summary of Safety and Efficacy Data (SSED) – UI 1614117,Qualitative/quantitative composition of ingredients.
Summary of Safety and Efficacy Data (SSED) –SPF Report 19851,SPF report 19578 (exploratory),CW FDA Report NT2017-029,UVA In vitro ISO24442 NT2017-047 ISO 24442 19986
Summary of Safety and Efficacy Data (SSED) – UI 1614117,SPF Report 19851.

Summary of Safety and Efficacy Data (SSED) – UI 1614357, Formula composition
Summary of Safety and Efficacy Data (SSED) – UI 1614357, Acnegenicity/Comedogenicity 4-Week clinical trial 20390 (CRL 2018-0724)
Summary of Safety and Efficacy Data (SSED) – UI 1614357, SPF Report for Study 19917
Summary of Safety and Efficacy Data (SSED) – UI 1614357, SPF Report for Study 19917, CW Report NT2017-035 (FDA),CW Report NT2017-051 (ISO 24443)

Summary of Safety and Efficacy Data (SSED) – UI 1613641:Kobo Non-Nano Patent Information:U.S. Patent Application No.: 12/331,593 for Zinc Oxide Aqueous and Non-Aqueous Dispersions including its making and use in suncare product.19653 – Sensory Descriptive Analysis of Zinc Sunscreen - Body PDG-US-NJMOR013-17 - Project Ghost Sensory Internal Fit to Concept Test Coppertone, 19471 – Acne/Comedo – refer to study questionnaire results
Summary of Safety and Efficacy Data (SSED) – UI 1613641, Acne/ Comedogen ic test_19471
Summary of Safety and Efficacy Data (SSED) – UI 1613641, 18225 An Assessment of Sunscreens and their Effect on Skin Conditioning
Summary of Safety and Efficacy Data (SSED) – UI 1613641, formula Y49-103, 18475 SUN PROTECTION FACTOR;
Summary of Safety and Efficacy Data (SSED) – UI 1613641,18475 SUN PROTECTION FACTOR; 18572 ULTRAVIOLET PROTECTION FACTOR A (UVAPF ASSAY). SR15-44 Critical Wave length FDA and ISO

Coppertone Dermatologists Recommendation Study for Merck Consumer Care by Hellebusch Research & Consulting, Inc. (HRC), August & September 2011
Summary of Safety and Efficacy Data (SSED) – UI 1612450: Formula composition
Summary of Safety and Efficacy Data (SSED) – UI 1612450: PT09-17 EVALUATION OF APPROPRIATENESS FOR USE OF A SUNSCREEN BY INDIVIDUALS WITH SENSITIVE SKIN AND ROSACEA
Summary of Safety and Efficacy Data (SSED) – UI 1612450
Summary of Safety and Efficacy Data (SSED) – UI 1612450: SR13-22 Final report – Sun protection factor (SPF)

Summary of Safety and Efficacy Data (SSED) – UI 1612389: PT08-04 EVALUATION OF SUNSCREEN FORMULAS DURING EXERCISE DURING PROFUSE SWEATING
Summary of Safety and Efficacy Data (SSED) – UI 1612389: SR13-35 FINAL REPORT – SUN PROTECTION FACTOR (SPF)
Summary of Safety and Efficacy Data (SSED) – UI 1612389: PT12-29 EVALUATION OF THE EFFECT OF TEST MATERIALS ON SKIN SURFACE HYDRATION AND TRANS-EPIDERMAL WATER LOSS FOLLOWING A SINGLE APPLICATION; PT11-46 : THE ASSESSMENT OF SPRAY-ON SUNSCREENS AND THEIR EFFECT ON SKIN CONDITIONING PROPERTIES
Summary of Safety and Efficacy Data (SSED) – UI 1612389: HT201217 AN IN-USE EVALUATION TO DETERMINE THE DERMAL IRRITATION AND COMEDOGENIC-ACNEGENIC POTENTIAL OF A SUNSCREEN PRODUCT - FINAL REPORT., HT200904 HUMAN COMEDOGENICITY TEST"
Summary of Safety and Efficacy Data (SSED) – UI 1612389: SR 12-04 FINAL REPORT – CRITICAL WAVELENGTH IN VITRO UVA BROAD SPECTRUM TEST, SR13-35 FINAL REPORT – SUN PROTECTION FACTOR (SPF)

Summary of Safety and Efficacy Data (SSED) – UI 1612389: PT08-04 EVALUATION OF SUNSCREEN FORMULAS DURING EXERCISE DURING PROFUSE SWEATING
Summary of Safety and Efficacy Data (SSED) – UI 1612389: SR13-35 FINAL REPORT – SUN PROTECTION FACTOR (SPF)
Summary of Safety and Efficacy Data (SSED) – UI 1612389: Draft Claims Support for topical Vitamins for Coppertone Kids-6 May 2009
Summary of Safety and Efficacy Data (SSED) – UI 1612389: HT201217 AN IN-USE EVALUATION TO DETERMINE THE DERMAL IRRITATION AND COMEDOGENIC-ACNEGENIC POTENTIAL OF A SUNSCREEN PRODUCT - FINAL REPORT., HT200904 HUMAN COMEDOGENICITY TEST"
Summary of Safety and Efficacy Data (SSED) – UI 1612389: SR 12-04 FINAL REPORT – CRITICAL WAVELENGTH IN VITRO UVA BROAD SPECTRUM TEST, SR13-35 FINAL REPORT – SUN PROTECTION FACTOR (SPF)